Inhibition of the Id target Kif11 (with ispinesib treatment) in combination with chemotherapy also resulted in a loss of Id+ CSC subpopulations of tumor cells, ultimately leading to more effective debulking of the entire tumor (Figure 5g). Here, ID1 is linked to neoplasm.